CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
ReWalkdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02322125
NCT02322125N/ACompleted
CompareCT.gov

Restoring Walking With a Powered Exoskeleton After Complete and Sever Incomplete Spinal Cord Injury

University of Alberta·interventional·Posted Dec 22, 2014·Updated Oct 14, 2021

In Brief

A clinical study evaluating ReWalk for Spinal Cord Injury. Completed, enrolled 12 participants across 1 site.

Detailed Summary

Powered exoskeletons have emerged recently, promising to offer walking to individuals with severe spinal cord injury who are unable to walk. We will use the ReWalk exoskeleton to train walking in individuals with chronic, severe spinal cord injury (SCI). We will determine the characteristics of individuals who most benefit from such training, and identify the neuroplasticity induced by the training. We will further determine the feasibility of the ReWalk for home and community ambulation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injury
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 22, 2014
Enrollment StartJun 1, 2014
Primary CompletionAug 20, 2018
Study CompletionSep 26, 2018
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 11.5 years ago

Interventions

ReWalkdevice

Intensive training with the ReWalk to negotiate smooth ground, rough terrain indoors and outdoors, ascending and descending slopes and steps, in a home setting and in the community.